[HTML][HTML] TP53 mutation characteristics in therapy-related myelodysplastic syndromes and acute myeloid leukemia is similar to de novo diseases
Background TP53 mutation is more prevalent in therapy-related myeloid neoplasms (t-MN)
than their de novo counterparts; however, the pattern of mutations involving TP53 gene in t …
than their de novo counterparts; however, the pattern of mutations involving TP53 gene in t …
TP53 mutation characteristics in therapy-related myelodysplastic syndromes and acute myeloid leukemia is similar to de novo diseases
CY Ok, KP Patel, G Garcia-Manero… - Journal of Hematology …, 2015 - go.gale.com
Background TP53 mutation is more prevalent in therapy-related myeloid neoplasms (t-MN)
than their de novo counterparts; however, the pattern of mutations involving TP53 gene in t …
than their de novo counterparts; however, the pattern of mutations involving TP53 gene in t …
[PDF][PDF] TP53 mutation characteristics in therapy-related myelodysplastic syndromes and acute myeloid leukemia is similar to de novo diseases
CY Ok, KP Patel, G Garcia-Manero, MJ Routbort… - 2015 - academia.edu
Background: TP53 mutation is more prevalent in therapy-related myeloid neoplasms (t-MN)
than their de novo counterparts; however, the pattern of mutations involving TP53 gene in t …
than their de novo counterparts; however, the pattern of mutations involving TP53 gene in t …
[HTML][HTML] TP53 mutation characteristics in therapy-related myelodysplastic syndromes and acute myeloid leukemia is similar to de novo diseases
CY Ok, KP Patel, G Garcia-Manero… - … of Hematology & …, 2015 - jhoonline.biomedcentral.com
TP53 mutation is more prevalent in therapy-related myeloid neoplasms (t-MN) than their de
novo counterparts; however, the pattern of mutations involving TP53 gene in t-MN versus de …
novo counterparts; however, the pattern of mutations involving TP53 gene in t-MN versus de …
[PDF][PDF] TP53 mutation characteristics in therapy-related myelodysplastic syndromes and acute myeloid leukemia is similar to de novo diseases
CY Ok, KP Patel, G Garcia-Manero, MJ Routbort… - 2015 - researchgate.net
Background: TP53 mutation is more prevalent in therapy-related myeloid neoplasms (t-MN)
than their de novo counterparts; however, the pattern of mutations involving TP53 gene in t …
than their de novo counterparts; however, the pattern of mutations involving TP53 gene in t …
TP53 mutation characteristics in therapy-related myelodysplastic syndromes and acute myeloid leukemia is similar to de novo diseases
CY Ok, KP Patel, G Garcia-Manero… - … of hematology & …, 2015 - pubmed.ncbi.nlm.nih.gov
Background TP53 mutation is more prevalent in therapy-related myeloid neoplasms (t-MN)
than their de novo counterparts; however, the pattern of mutations involving TP53 gene in t …
than their de novo counterparts; however, the pattern of mutations involving TP53 gene in t …
[PDF][PDF] TP53 mutation characteristics in therapy-related myelodysplastic syndromes and acute myeloid leukemia is similar to de novo diseases
CY Ok, KP Patel, G Garcia-Manero, MJ Routbort… - 2015 - Citeseer
Background: TP53 mutation is more prevalent in therapy-related myeloid neoplasms (t-MN)
than their de novo counterparts; however, the pattern of mutations involving TP53 gene in t …
than their de novo counterparts; however, the pattern of mutations involving TP53 gene in t …
TP53 mutation characteristics in therapy-related myelodysplastic syndromes and acute myeloid leukemia is similar to de novo diseases
CY Ok, KP Patel, G Garcia-Manero, MJ Routbort… - Journal of Hematology & …, 2015 - infona.pl
Background TP53 mutation is more prevalent in therapy-related myeloid neoplasms (t-MN)
than their de novo counterparts; however, the pattern of mutations involving TP53 gene in t …
than their de novo counterparts; however, the pattern of mutations involving TP53 gene in t …
TP53 mutation characteristics in therapy-related myelodysplastic syndromes and acute myeloid leukemia is similar to de novo diseases.
CY Ok, KP Patel, G Garcia-Manero… - … of Hematology & …, 2015 - search.ebscohost.com
Background: TP53 mutation is more prevalent in therapy-related myeloid neoplasms (t-MN)
than their de novo counterparts; however, the pattern of mutations involving TP53 gene in t …
than their de novo counterparts; however, the pattern of mutations involving TP53 gene in t …
[PDF][PDF] TP53 mutation characteristics in therapy-related myelodysplastic syndromes and acute myeloid leukemia is similar to de novo diseases
CY Ok, KP Patel, G Garcia-Manero, MJ Routbort… - 2015 - cyberleninka.org
Background: TP53 mutation is more prevalent in therapy-related myeloid neoplasms (t-MN)
than their de novo counterparts; however, the pattern of mutations involving TP53 gene in t …
than their de novo counterparts; however, the pattern of mutations involving TP53 gene in t …